{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:01:38Z","timestamp":1771549298978,"version":"3.50.1"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"Background<\/jats:title>Diabetes has become a global pandemic, posing a sustained threat to human health, primarily due to its associated complications. Left ventricular diastolic dysfunction (LVDD) is a prevalent cardiac complication among patients with diabetes. Since most patients are asymptomatic and lack relevant biomarkers, LVDD has not attracted significant attention from clinicians. The neutrophil-to-lymphocyte ratio (NLR) is a widely studied inflammation biomarker that has been suggested to be linked to various medical conditions, including cardiac diseases. However, its association with LVDD among patients with type 2 diabetes mellitus (T2DM) has not been explored.<\/jats:p><\/jats:sec>Aim<\/jats:title>To clarify the relationship between NLR and LVDD among patients with type 2 diabetes.<\/jats:p><\/jats:sec>Methods<\/jats:title>We conducted a cross-sectional study using medical records from 855 patients diagnosed with T2DM who were admitted to the Endocrinology department at Wuhan Union Hospital. According to the ASE\/EACVI 2016 recommendations, these patients were categorized into two groups based on sonographic parameters: patients with normal left ventricular diastolic function (the non-LVDD group) and patients with LVDD (the LVDD group). NLR values were calculated and divided into three different levels. Statistical analysis was conducted to evaluate the correlation between NLR levels and the prevalence of LVDD.<\/jats:p><\/jats:sec>Results<\/jats:title>The prevalence of LVDD among hospitalized patients with T2DM in our study was 47.8% (409\/855). The mean NLR value of the LVDD group was significantly higher compared with the non-LVDD group [1.60 (1.24-2.05) vs 1.85 (1.44-2.31), P&lt;0.001]. The prevalence of LVDD in the three different NLR levels was 35.51% (76\/214), 49.27% (203\/412), and 56.77% (130\/229), respectively. Unjustified logistic analysis showed that NLR levels were positively associated with the prevalence of LVDD (P &lt;0.001). Compared to the low level of NLR, the unadjusted odds ratios (OR) of LVDD at the medium and high levels were 1.764 (1.255-2.478, P=0.001) and 2.384 (1.626-3.497, P&lt;0.001), respectively (P for trend &lt;0.001).<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Our findings suggest that the NLR is a potential indicator for assisting clinicians in identifying LVDD in patients with T2DM. Patients with elevated NLR levels may be at a greater risk of developing LVDD than those with lower NLR levels, which may require attention and interventions to prevent patients from progressing into heart failure.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1499713","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:11:10Z","timestamp":1736485870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between neutrophil-to-lymphocyte ratio and left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"15","author":[{"given":"Xueyang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinze","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement from the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","article-title":"Epidemiology of heart failure in diabetes: a disease in disguise","volume":"67","author":"Hoek","year":"2024","journal-title":"Diabetologia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.10.039","article-title":"Asymptomatic left ventricular diastolic dysfunction","volume":"13","author":"Kosmala","year":"2020","journal-title":"JACC: Cardiovasc Imaging"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"IJMS"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087397","article-title":"Neutrophil-to-lymphocyte ratio is an independent risk factor for coronary artery disease in central obesity","volume":"24","author":"Bagyura","year":"2023","journal-title":"IJMS"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1808-4","article-title":"Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)","volume":"17","author":"Yuan","year":"2019","journal-title":"J Transl Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4149\/BLL_2021_078","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"BLL"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-018-0472-y","article-title":"The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: The Rotterdam Study","volume":"34","author":"Fest","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: A report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew082","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the European association of cardiovascular imaging","volume":"17","author":"Nagueh","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(23)00128-6","article-title":"Predicting and preventing heart failure in type 2 diabetes","volume":"11","author":"Pandey","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118787415","article-title":"The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis","volume":"15","author":"Bouthoorn","year":"2018","journal-title":"Diabetes Vasc Dis Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.676862","article-title":"Prevalence and predictors of left ventricular diastolic dysfunction in Malaysian patients with type 2 diabetes mellitus without prior known cardiovascular disease","volume":"8","author":"Chee","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34667","article-title":"Left ventricular diastolic dysfunction in type 2 diabetes mellitus: A single-centre observational study from a tertiary care hospital in south India","volume":"5","author":"Cm","year":"2023","journal-title":"Cureus"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0168-x","article-title":"Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes","volume":"14","author":"Fontes-Carvalho","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31626","article-title":"Association of glycosylated haemoglobin (HbA1c) level with left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"14","author":"Guria","year":"2022","journal-title":"Cureus"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3270617","article-title":"Cardiovascular autonomic neuropathy is an independent risk factor for left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"2017","author":"Jin","year":"2017","journal-title":"BioMed Res Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.a2016.0064","article-title":"Left ventricular diastolic dysfunction in normotensive postmenopausal women with type 2 diabetes mellitus","volume":"24","author":"Maiello","year":"2017","journal-title":"Cardiol J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e081269","DOI":"10.1136\/bmjopen-2023-081269","article-title":"Can glycated haemoglobin (HbA1c) be used as a predictor of left ventricular diastolic dysfunction in non-hypertensive patients with newly diagnosed type 2 diabetes mellitus: a cross-sectional study at a tertiary care centre in Eastern India","volume":"14","author":"Porel","year":"2024","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4109078","article-title":"Duration of diabetes, glycemic control, and risk of heart failure among adults with diabetes: A cohort study","volume":"108","author":"Yang","year":"2022","journal-title":"J Clin Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jchf.2021.06.005","article-title":"Duration of diabetes and incident heart failure","volume":"9","author":"Echouffo-Tcheugui","year":"2021","journal-title":"JACC: Heart Failure"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2016.05.004","article-title":"Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function","volume":"26","author":"Zoppini","year":"2016","journal-title":"Nutrition Metab Cardiovasc Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-8-58","article-title":"Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders","volume":"8","author":"Dinh","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7583690","article-title":"Biomarkers of inflammation in left ventricular diastolic dysfunction","volume":"2019","author":"Mocan","year":"2019","journal-title":"Dis Markers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1586\/14779072.2016.1154788","article-title":"Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update","volume":"14","author":"Afari","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3117396","article-title":"The association between neutrophil-to-lymphocyte ratio and glycemic control in type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"2023","author":"Adane","year":"2023","journal-title":"J Diabetes Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6219545","article-title":"Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: A cross-sectional study","volume":"2020","author":"Wan","year":"2020","journal-title":"J Diabetes Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13098-020-00562-y","article-title":"Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history","volume":"12","author":"Wang","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1039700","article-title":"Predictive value of novel inflammatory markers platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio in arterial stiffness in patients with diabetes: A propensity score\u2013matched analysis","volume":"13","author":"Ning","year":"2022","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2015.01.001","article-title":"Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease","volume":"41","author":"Verdoia","year":"2015","journal-title":"Diabetes Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American diabetes association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1499713\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:11:13Z","timestamp":1736485873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1499713\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":35,"alternative-id":["10.3389\/fendo.2024.1499713"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1499713","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"article-number":"1499713"}}